JON HALLBERG: Well, I have a personal story with one of my patients who, in-- I'll use the pronoun "they"-- they were on vacation and in their mid-80s, and took a gummy before going to bed just to sort of help with sleep-- woke up in the middle of the night, thick speech, felt very strange, a little out of body, woke up spouse, worried that this person was having a stroke, went to the hospital, got worked up, had an MRI, everything clear
A study in The New England Journal of Medicine showed that tirzepatide (a dual GLP1/GIP receptor agonist) significantly reduced symptoms of OSA and weight in people with moderate to severe OSA and obesity
Clinical trials have demonstrated weight loss benefits across the dose range, and a lower tolerated dose that you can continue is preferable to discontinuing treatment entirely due to side effects
Trigeminal Neuralgia Treatment Cooling the Fire
Retatrutide includes GLP-1 activity, but it is not only a GLP-1 drug
Are you comfortable with self-injection